33 results
8-K
EX-99.1
CHRS
Coherus Biosciences Inc
13 Mar 24
Coherus BioSciences Reports Fourth Quarter, Full Year 2023 Financial Results and Provides Current Business Update
4:16pm
is expected to result in a reduction in workforce of 30% by the end of 2024, including 35 employees associated with the ophthalmology divestiture … of the reduction of workforce in 2024; and Coherus’ expectations that it will be able to realize value in the future from its pipeline.
Such forward-looking
8-K
EX-99.1
CHRS
Coherus Biosciences Inc
8 May 23
Coherus BioSciences Reports First Quarter 2023 Financial Results and Business Highlights
4:16pm
-based compensation expense, loss on debt extinguishment and restructuring charges related to our reduction in workforce. These non-GAAP financial … extinguishment
Restructuring charges related to reduction in workforce(1)
Non-GAAP net loss
GAAP net loss per share, basic and diluted
Non-GAAP net loss per
8-K
EX-99.1
CHRS
Coherus Biosciences Inc
9 May 24
Coherus BioSciences Reports First Quarter 2024 Financial Results and Provides Business Update
4:17pm
, loss on debt extinguishment and restructuring charges related to our reduction in workforce. These non-GAAP financial measures are not prepared …
Impairment of out-license asset and remeasurement of CVR liability, net
Restructuring charges related to reduction in workforce(1)
Amortization
8-K
EX-99.1
CHRS
Coherus Biosciences Inc
2 Aug 23
Coherus BioSciences Reports Second Quarter 2023 Financial Results and Business Highlights
4:05pm
reduction in workforce. These non-GAAP financial measures are not prepared in accordance with GAAP, do not serve as an alternative to GAAP and may …
Adjustments:
Stock-based compensation expense(1)
Loss on debt extinguishment
Restructuring charges related to reduction in workforce(1)
Non-GAAP net
8-K
EX-99.1
CHRS
Coherus Biosciences Inc
6 Nov 23
Coherus BioSciences Reports Third Quarter 2023 Financial Results and Business Highlights
4:31pm
of intangible assets, loss on debt extinguishment and restructuring charges related to our reduction in workforce. These non-GAAP financial measures … on debt extinguishment
Restructuring charges related to reduction in workforce(1)
Acquisition-related costs, including amortization of intangibles(2)
Non
8-K
EX-99.1
h1mnhlfdrta9pr
16 Jun 23
Coherus to Acquire Surface Oncology
7:06am
DRSLTR
td9tl
15 Sep 14
Correspondence regarding draft registration statement
12:00am
425
62furx 80yuhy4g
16 Jun 23
Business combination disclosure
5:12pm
8-K/A
EX-99.1
r7vk91ldqujpuwz
6 Nov 23
Report of Independent Registered Public Accounting Firm
6:07am
S-4
cimxh2
7 Jul 23
Registration of securities issued in business combination transactions
5:03pm
S-4/A
s5b5 5tlb8p09yeo
24 Jul 23
Registration of securities issued in business combination transactions (amended)
4:42pm
424B3
iwtvysx
26 Jul 23
Prospectus supplement
4:59pm
DRS
EX-10.8
d6sdjln8fnl71xl
4 Aug 14
Draft registration statement
12:00am
425
54pmrti
16 Jun 23
Business combination disclosure
8:08am